News & Events :: Pasithea Therapeutics Corp. (KTTA)

Recent News View All News

Jun 2, 2026 7:02am EDT

Pasithea Therapeutics Announces Orphan Drug Designation by FDA of PAS-004 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

May 4, 2026 7:01am EDT

Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings